Secondary amyloidosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 10: | Line 10: | ||
|+ | |+ | ||
|- | |- | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" | | | align="center" style="background:#4479BA; color: #FFFFFF;" | | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" | | | align="center" style="background:#4479BA; color: #FFFFFF;" | | ||
|- | |- | ||
| rowspan=" | | rowspan="4" align="center" style="background:#f0f0f0;" |Nephrotic syndrome causes | ||
| | | | ||
* | * Minimal change disease | ||
* | * | ||
|- | |- | ||
| | | | ||
* | * Membranous nephropathy | ||
* | * | ||
|- | |- | ||
| | | | ||
* | * Focal segmental glomerulosclerosis | ||
* | * | ||
|- | |- | ||
| | | | ||
* | * Diabetic nephropathy | ||
* | * | ||
|- | |- | ||
| rowspan="5" |Hepatosplenomegaly causes | |||
| | | | ||
* | * Metabolic disorders | ||
* | * | ||
|- | |- | ||
| | | | ||
* | * Chronic liver disease and portal hypertension | ||
|- | |- | ||
| | | | ||
* | * Infectoins | ||
* | * | ||
|- | |- | ||
| | | | ||
* | * Hematologic disorders | ||
* | * | ||
|- | |- | ||
| | | | ||
* | * Rare disorders | ||
* | * | ||
|- | |- | ||
|Peripheral neuropathy causes | |||
| | | | ||
* | |||
* | |||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
|+ | |+ | ||
|- | |- | ||
| | | align="center" style="background:#f0f0f0;" | | ||
| | | | ||
* | * | ||
|- | |||
| | |||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|- | |- | ||
| | | | ||
| | | | ||
* | * | ||
|} | |} | ||
Revision as of 19:49, 4 November 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.
Differentiating Amyloidosis from other Diseases
Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.
Nephrotic syndrome causes |
|
| |
| |
| |
Hepatosplenomegaly causes |
|
| |
| |
| |
| |
Peripheral neuropathy causes |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|